Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.02 - Poster Session 1 - Novel Cancer Genes and Pathways
- Type: Poster Session
- Track: Biology
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.02-004 - Differential pathway disruption in lung adenocarcinomas from current and never smokers - A multi-omics data integration analysis
09:30 - 09:30 | Author(s): K.L. Thu
- Abstract
Loading...
-
+
P1.07 - Poster Session 1 - Surgery
- Type: Poster Session
- Track: Surgery
- Presentations: 48
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.07-014 - Effect of Advanced Age on Peri-Operative Outcomes after Robotic-Assisted Pulmonary Lobectomy: Retrospective Analysis of 180 Consecutive Cases
09:30 - 09:30 | Author(s): W.W. Zhang
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-036 - The efficacy and safety of sunitinib in EGFR-TKI pretreated advanced non-small cell lung cancer: a retrospective review from Chinese patients at a single institution
09:30 - 09:30 | Author(s): L. Jiang
- Abstract
Loading...
-
+
MO02 - General Thoracic and Minimally Invasive Surgery
- Type: Mini Oral Abstract Session
- Track: Surgery
- Presentations: 11
- Moderators:M. Tajiri
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside 110 A+B, Level 1
-
+
MO02.07 - Effect of Obesity on Peri-Operative Outcomes after Robotic-Assisted Pulmonary Lobectomy: Retrospecitve Analysis of 227 Consecutive Patients
11:00 - 11:05 | Author(s): M.R. Thau
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.07 - Poster Session 2 - Surgery
- Type: Poster Session
- Track: Surgery
- Presentations: 49
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.07-027 - Retrospective Analysis of 236 Consecutive Robotic-Assisted Pulmonary Lobectomies at a Single Institution: A Bi-Phasic Learning Curve
09:30 - 09:30 | Author(s): K.L. Rodriguez
- Abstract
Loading... -
+
P2.07-043 - Effect of Female Gender on Peri-Operative Outcomes after Robotic-Assisted Pulmonary Lobectomy: Retrospective Analysis of 180 Consecutive Cases
09:30 - 09:30 | Author(s): F.O. Velez-Cubian
- Abstract
Loading...
-
+
P2.08 - Poster Session 2 - Radiotherapy
- Type: Poster Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.08-026 - Prospective Study of Stage I Non-Small-Cell Lung Cancer Treated with Hypofractionated SIB IMRT
09:30 - 09:30 | Author(s): W. Zhang
- Abstract
Loading...
-
+
P3.08 - Poster Session 3 - Radiotherapy
- Type: Poster Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 28
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.08-016 - Clinical outcome of [18F] FDG-PET/CT versus conventional CT based planning for radiotherapy in locally advanced NSCLC patients: a propensity-score matching study
09:30 - 09:30 | Author(s): W. Zhang
- Abstract
Loading...
-
+
P3.10 - Poster Session 3 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 55
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.10-044 - Overall Survival analysis results of TFINE Study (CTONG 0904): Different Dose Docetaxel plus Cisplatin as First-line Chemotherapy and Then Maintenance Therapy with Single Agent Docetaxel for Advanced non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Lu
- Abstract
Loading...
-
+
P3.11 - Poster Session 3 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.11-005 - Randomized, open-label, multi-center study of Gefitinib dose-escalation (500mg/d versus 250mg/d) in advanced NSCLC patient achieved Stable Disease (SD) after one-month Gefitinib treatment
09:30 - 09:30 | Author(s): L. Zhang
- Abstract
Loading...
